Napo Pharmaceuticals, Inc.
www.napopharma.comNapo Pharmaceuticals, Inc. focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace — every country, every population, every channel — regardless of social or economic status. Napo’s mission is to provide novel medicines to high-margin western markets, while leveraging economies of scale in emerging and developing markets. We are committed to ensuring sustainable access to our drugs for 80% of the world’s population normally excluded from novel drug access, through existing and new partnerships with local pharmaceutical companies and distribution organizations, as well as with relief organizations to address disaster situations, such as the cholera outbreak in Haiti. Napo’s unique business model provides long-term sustainability. Napo will work with local organizations to commercialize in emerging and developing countries. The access created in such local markets is sustainable — no donations, charity, or grants are required.
Read moreNapo Pharmaceuticals, Inc. focuses on the development and commercialization of proprietary pharmaceuticals for the global marketplace — every country, every population, every channel — regardless of social or economic status. Napo’s mission is to provide novel medicines to high-margin western markets, while leveraging economies of scale in emerging and developing markets. We are committed to ensuring sustainable access to our drugs for 80% of the world’s population normally excluded from novel drug access, through existing and new partnerships with local pharmaceutical companies and distribution organizations, as well as with relief organizations to address disaster situations, such as the cholera outbreak in Haiti. Napo’s unique business model provides long-term sustainability. Napo will work with local organizations to commercialize in emerging and developing countries. The access created in such local markets is sustainable — no donations, charity, or grants are required.
Read moreCountry
State
California
City (Headquarters)
San Francisco
Industry
Employees
11-50
Founded
2002
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Clinical Research and Medical Affairs
Email ****** @****.comPhone (***) ****-****Co - Founder
Email ****** @****.comPhone (***) ****-****National Business Director
Email ****** @****.comPhone (***) ****-****Director Clinical Operations
Email ****** @****.comPhone (***) ****-****
Technologies
(35)